BioXcel Therapeutics Inc

NASDAQ:BTAI   11:55:44 AM EDT
29.58
+1.53 (+5.46%)
Products

Bioxcel Therapeutics Receives FDA Breakthrough Therapy Designation For Bxcl501

Published: 03/15/2021 11:23 GMT
BioXcel Therapeutics Inc (BTAI) - Bioxcel Therapeutics Receives FDA Breakthrough Therapy Designation for Bxcl501 for the Acute Treatment of Agitation Associated With Dementia.